Relation of Biomarkers of Inflammation and Oxidative Stress with Hypertension Occurrence in Lone Atrial Fibrillation

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Polovina, Marija M ^a,b   Ostojic, Miodrag C ^b   Potpara, Tatjana S ^a,b  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; BIOLOGICAL MARKER; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; BODY MASS; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HUMAN; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; LUNG EMBOLISM; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; BLOOD; IMMUNOLOGY; INFLAMMATION; METABOLISM; MIDDLE AGED; OXIDATIVE STRESS; PHYSIOLOGY;

ADULT; ATRIAL FIBRILLATION; BIOMARKERS; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; FEMALE; HUMANS; INFLAMMATION; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATIVE STRESS;

EID: 84937020186     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/653026     Document Type: Article

References (24)

1. A. J. Camm, P. Kirchhof, G. Y. Lip et al., "Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)," Europace, vol. 12, no. 10, pp. 1360-1420, 2010.
2. T. S. Potpara and G. Y. H. Lip, "Lone atrial fibrillation-an overview," International Journal of Clinical Practice, vol. 68, no. 4, pp. 418-433, 2014.
3. D. G. Katritsis, I. K. Toumpoulis, E. Giazitzoglou et al., "Latent arterial hypertension in apparently lone atrial fibrillation," Journal of Interventional Cardiac Electrophysiology, vol. 13, no. 3, pp. 203-207, 2005.
4. B. Weijs, R. Pisters, R. J. Haest et al., "Patients originally diagnosed with idiopathic atrial fibrillation more often suffer from insidious coronary artery disease compared to healthy sinus rhythm controls," Heart Rhythm, vol. 9, no. 12, pp. 1923-1929, 2012.
5. T. S. Potpara, G. R. Stankovic, B. D. Beleslin et al., "A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation. Implications of arrhythmia progression on prognosis: the Belgrade atrial fibrillation study," Chest, vol. 141, no. 2, pp. 339-347, 2012.
6. B. Weijs, C. B. de Vos, R. G. Tieleman et al., "The occurrence of cardiovascular disease during 5-year follow-up in patients with idiopathic atrial fibrillation," Europace, vol. 15, no. 1, pp. 18-23, 2013.
7. K. C. Sung, J. Y. Suh, B. S. Kim et al., "High sensitivity Creactive protein as an independent risk factor for essential hypertension," American Journal of Hypertension, vol. 16, no. 6, pp. 429-433, 2003.
8. C. Tsioufis, D. Syrseloudis, A. Hatziyianni et al., "Relationships of CRP and P wave dispersion with atrial fibrillation in hypertensive subjects," American Journal of Hypertension, vol. 23, no. 2, pp. 202-207, 2010.
9. K. Friedrichs, S. Baldus, and A. Klinke, "Fibrosis in atrial fibrillation-role of reactive species and MPO," Frontiers in Physiology, vol. 3, article 214, 2012.
10. R. B. Schnabel, P. S. Wild, S. Wilde et al., "Multiple biomarkers and atrial fibrillation in the general population," PLoS ONE, vol. 9, no. 11, Article ID e112486, 2014.
11. D. I. Leftheriotis, K. T. Fountoulaki, P. G. Flevari et al., "The predictive value of inflammatory and oxidative markers following the successful cardioversion of persistent lone atrial fibrillation," International Journal of Cardiology, vol. 135, no. 3, pp. 361-369, 2009.
12. S.-M. Kim, J.-H. Lee, J.-R. Kim, D.-G. Shin, S.-H. Lee, and K.-H. Cho, "Female patients with atrial fibrillation have increased oxidizedandglycated lipoprotein properties and lower apolipoprotein A-I expression in HDL," International Journal of Molecular Medicine, vol. 27, no. 6, pp. 841-849, 2011.
13. M. K. Chung, D. O. Martin, D. Sprecher et al., "C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation," Circulation, vol. 104, no. 24, pp. 2886-2891, 2001.
14. B. Richter, M. Gwechenberger, A. Socas et al., "Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation," Clinical Research in Cardiology, vol. 101, no. 3, pp. 217-225, 2012.
15. T. S. Potpara, M. M. Polovina, M.M. Licina, J. M. Marinkovic, M. S. Prostran, and G. Y. H. Lip, "Reliable identification of 'truly low' thromboembolic risk in patients initially diagnosed with 'lone' atrial fibrillation: the belgrade atrial fibrillation study," Circulation: Arrhythmia and Electrophysiology, vol. 5, no. 2, pp. 319-326, 2012.
16. M. K. Stiles, B. John, C. X. Wong et al., "Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the 'second factor'," Journal of the American College of Cardiology, vol. 53, no. 14, pp. 1182-1191, 2009.
17. J. A. Vílchez, V. Roldán, D. Hernández-Romero, M. Valdés, G. Y. Lip, and F. Marín, "Biomarkers in atrial fibrillation: an overview," International Journal of Clinical Practice, vol. 68, no. 4, pp. 434-443, 2014.
18. M. Polovina, T. Potpara, V. Giga, J. Stepanović, and M. Ostojić, "Impaired endothelial function in lone atrial fibrillation," Vojnosanitetski Pregled, vol. 70, no. 10, pp. 908-914, 2013.
19. J. Li, J. Solus, Q. Chen et al., "Roleof inflammation and oxidative stress in atrial fibrillation," Heart Rhythm, vol. 7, no. 4, pp. 438-444, 2010.
20. P. T. Ellinor, A. Low, K. K. Patton, M.A. Shea, and C.A. MacRae, "C-reactive protein in lone atrial fibrillation," American Journal of Cardiology, vol. 97, no. 9, pp. 1346-1350, 2006.
21. H. D. Sesso, J. E. Buring, N. Rifai, G. J. Blake, J. M. Gaziano, and P.M. Ridker, "C-reactive protein and the risk of developing hypertension," The Journal of the American Medical Association, vol. 290, no. 22, pp. 2945-2951, 2003.
22. S. G. Lakoski, M. Cushman, D. S. Siscovick et al., "The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA)," Journal of Human Hypertension, vol. 25, no. 2, pp. 73-79, 2011.
23. J. Hulthe and B. Fagerberg, "Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR study)," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 7, pp. 1162-1167, 2002.
24. C. Rostagno, F. Bacci, M. Martelli, A. Naldoni, G. Bertini, and G. Gensini, "Clinical course of lone atrial fibrillation since first symptomatic arrhythmic episode," The American Journal of Cardiology, vol. 76, no. 11, pp. 837-839, 1995.